Origin of Sars-Cov-2-An Algae Virus with Atypical Virulence
Gaurav Kulshrestha*
Department of Pediatrics, Armed Forces Medical College, Pune, Maharashtra, India*Address for Correspondence: Gaurav Kulshrestha, Department of Pediatrics, Armed Forces Medical College, CH 199 Kedar Nagar, Shahganj, Pune, Maharashtra, India, Tel: 088-069-496-81; ORCiD: 0000-0002-6179-4663; E-mail: [email protected]
Submitted: 23 July 2020; Approved: 14 September 2020; Published: 15 September 2020
Citation this article: Kulshrestha G. Origin of Sars-Cov-2-An Algae Virus with Atypical Virulence. American J Current App Res Microbiol. 2020;2(1): 009-014.
Copyright: © 2020 Kulshrestha G. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Keywords:COVID 19; Chlamydomonas reinhardtii; SOUL protein; Chimeric virus; O- linked glycans
Download Fulltext PDF
The present pandemic COVID-19 an ongoing havoc with no robust strategy till now despite of aggressive researches and treatment protocols. This could be attributed to poorly understood etiopathogenesis, non-specific hypotheses and theories. Many of the studies have already described its hybrid nature with other Coronaviruses. The SARS-CoV-2, SARS-CoV, and MERS-CoV have similarities in their phenotypic and genomic structure which can influence their pathogenesis. Here we discuss that SARS-COV-2 is a chimeric algae virus (combination of SARS-CoV and microalgae) could be accidentally evolved and leaked in laboratory while making forthcoming vaccines. The Chlamydomonas reinhardtii is a unique unicellular microalgae (common ancestor of plants and animals) with extraordinary genetic potential to become a chimera and can manifest in difficult conditions to serve as a platform to produce various recombinant proteins, vaccines, hormones and biofuels. The recent studies also shows the existence of Algae virus and its pathogenicity towards humans. The atypical clinical features like silent hypoxia, loss of taste and smell, vasculotropic effect could be easily decoded by this chimera. One should also explore possibility of new genetically modified microalgae based recombinant oral and nasal vaccines.
Introduction
Coronaviruses (CoVs) which are involved in multiple respiratory and gastrointestinal illnesses since early 21st century in humans and vertebrates are members of the subfamily Coronavirinae, family Coronaviridae and the order Nidovirales [1]. The recent 2019 havoc caused by the novel coronavirus SARS-CoV-2 resulting in an unusual clinical manifestations with viral pneumonia and other atypical complications has taken the world by a storm. Based on its genomic configuration and phylogenetic relationships, the SARS-CoV-2 belongs to genera Beta coronavirus. This has almost similar sequences as that of severe acute respiratory syndrome-related coronaviruses (SARS-CoV) and both the viruses use Angiotensin Converting Enzyme 2 (ACE2) as the entry receptor [2].
Chlamydomonas reinhardtii is a unicellular flagellate, eukaryotic green alga also known as Last Eukatyotic Common Ancestor (LECA) or plant like animal due to its unique properties. It is commonly found in the soil and can either assimilate CO2 through photosynthesis or use certain organic compounds such as acetate as carbon sources. It can grow in heterotrophic and fermentative environment. Active research areas involving Chlamydomonas reinhardtii include photosynthesis, flagellar proteins, gene regulation and more recently as an excellent platform for recombinant therapeutic proteins synthesis of biological importance like HMBG1, VEGF, vaccines, hormones and biofuels. The genome of Chlamydomonas reinhardtii also includes a complex set of non-coding RNA genes, including endogenous microRNAs. Recent discoveries in the field of molecular genetics like indexed insertional mutants, most important targeted gene editing by CRISPR (Clusters of regularly interspaced short palindromic repeats), Optogenetics, Channelrhodopsins chimera, IFT (Intraflagellar Transport) of granule like particles, kairomones induced chemosensory property have made this organism a perfect role model. It can dispersed to extended distances by wind and survive air transportation [3,4]. Humans and Chlamydomonas shares 706 protein families (806 and 774 proteins, respectively) [5].
Chimeric Virus
The Virus and microalgae interactions exist in the nature. The discovery of Algae virus in throat of human population in John Hopkins center is an example of the same [6]. The Algevir also acts as an expression system for microalgae based on viral vectors [7]. As per our hypothesis, this COVID-19 virus possibly evolved accidentally during passing through the different cell lines of Chlamydomonas reinhardtii over the time and leaked while manufacturing future vaccines in laboratory. It seems to be a combination of SARS-CoV and genome of microalgae chloroplast i.e., Chlamydomonas reinhardtii. So it has retained the old properties of SARS-CoV like features with add on features of transgenic microalgae which is responsible for its unpredictable behavior now.
Across the world basic ongoing researches involving passage of bat SARS-CoV-like coronaviruses in cell culture and/or animal models in biosafety level 12 laboratories has been noticed [8], and there are documented instances of laboratory leaks too [9]. The presence of polybasic furin cleavage at spike binding protein also strengthen the possibility of accidental evolution in laboratory due to presence of similar manipulations in Pf25 and CTB domain in nanoparticle vaccine [10], H9 avian influenza reasserting with polybasic cleavage site and H5 avian influenza virus with haemagglutinin cleavage site a highly pathogenic phenotype in chicken which were not present in other beta lineage bat or in pangolins CoVs till now [11,12].
Why Chlamydomonas reinhardtii chloroplast genome in SARS-CoV-2 chimera?
Genetically, SARS-CoV-2 was less similar to SARS-CoV (about 79%) and MERS-CoV (about 50%) but more closer to RaTG13 bat coronavirus (96%). To date a virus identical to SARS-CoV-2 has not been identified in bats or any other nonhuman species, making its origin unclear [13]. Apart from having SARS-CoV genomic features this chimera also exhibits certain exclusive properties of microalgae Chlamydomonas reinhardtii like the presence of 5’UTR and 3’UTR for binding of viral and cellular proteins [14], 12 Radial Spoke Proteins, molecular chaperones also show lot of similarity structurally and functionally. The Radial spoke proteins are 3-D structure ‘T’ shaped glycoproteins with thin stalk and bulbous head appear to have homologs in other organisms, including Homo sapiens, indicating that not only the structure, but also many of the proteins of it have been preserved throughout evolution. Many of the newly identified proteins in the spoke stalk are predicted to contain domains associated with signal transduction, including Ca2+-, AKAP- and nucleotide-binding domains. This suggests that the spoke stalk is both a scaffold for signaling molecules and itself a transducer of signals [15]. Moreover, in addition to the recently described HSP40/HSP70 family member, a second spoke stalk protein is predicted to be a molecular Chaperone [16,17]. The presence of Sporangin type of serine protease, papain type cysteine protease, Arginine methyltransferase in Chlamydomonas reinhardtii further added to its uniqueness [18].
The presence of high catalytic efficiency which was recently proven for 3C like main protease (Mpro) in SARS-CoV-2 might be due to presence of above serine and papain type cysteine proteases too in the eye spot of Chlamydomonas reinhardtii [19]. The above mentioned characteristics could be a possibility of high infectivity rate in humans.
High ACE 2 receptor affinity
SARS-CoV-2 binds to ACE2 receptors which are found on the epithelia of lungs, small intestine, oral and nasal mucosa, nasopharynx by its Spike and allows virions to enter and infect cells. In order to complete entry into the cell, the spike protein has to be primed by a protease called TMPRSS2, similar to SARS-CoV [20]. The high affinity of SARS-CoV-2 towards ACE2 receptors as compared to previous SARS viruses could be due to chimeric structure binding protein Spike Protein (SP) and Receptor Binding Domain (RBD). Chlamydomonas reinhardtii chloroplast also expressed three Antihypertensive Peptides (AHP) as a fusion protein [21]. A hypertensive oral vaccine has been developed by ACE2 binding receptors using above microalgae as a part of immunotherapy is an exclusive example for the same [22].
Exclusive RNA processing enzymes in Chlamydomonas reinhardtii
Besides RNA dependent RNA polymerase, RNA helicase, and protease activities, which are shared by all RNA viruses, the coronavirus replicase was recently predicted to employ a variety of RNA processing enzymes that are not or extremely rare found in other RNA viruses and include putative sequence-specific endoribonuclease, 30-to-50 exoribonuclease, ADP ribose 10-phosphatase, 20-O-ribose methyltransferase and in a subset of group 2 coronaviruses, cyclic phosphodiesterase activities [23]. These enzymes which are absent in other RNA viruses of coronaviridae have already expressed in Chlamydomonas reinhardtii and studied in many in-vitro molecular studies [24].
Inimitable eyespot Proteome
Chlamydomonas reinhardtii chloroplast eye spot proteome contains an exclusive Haem binding protein (HBPs)/SOUL protein. The first member of this group of HBPs was found to be specifically located in the retina and pineal gland in chicken. Because Descartes considered the pineal gland as the soul, hence named by Zylka and Reppert accordingly [25]. This SOUL protein has two terminals N-terminal and C-terminal. The N-terminal domain could function as a sorting motif for eyespot localization and might be cleaved after sorting, resulting in a smaller protein. The C-terminus has HBP domain, indicating that it may be able to bind heme or its variants. Alignments of amino acid sequences from Chlamydomonas reinhardtii SOUL3 and homologous proteins from mammals (mouse and human) shows the highest similarity at this end [26].
The eyespot proteome and phosphoproteome which contains various protein Kinases and phosphatases (Serine/Threonine PPs) which indicates that light signal cascades may involve regulation by reversible protein phosphorylation [27]. The importance of diverse post translational protein modifications ie, methylation beside reversible phosphorylation in the regulation of protein stability, localization, activity and protein-protein interactions in cell organelles are also evident in recent years [28]. The methylation of 23 eyespot proteins have been discovered at Lysine and/or Arginine residues which increases their basicity and hydrophobicity without altering their charge [29], as this important reaction at lysine residue is a key binding strategy of SARS-CoV-2 RBP with ACE2 receptor [30].
Presence of O-linked glycans
A highly conserved and linear hydroxyproline-bound O-glycans were isolated from outer cell wall glycoproteins of the unicellular green alga Chlamydomonas reinhardtii [31]. It could create mucin like domain that possible act as an epitopes shield in viruses which helps in immunoevasion [32].
Analogous polybasic furin cleavage sites
The other prototypical neuropeptide precursors and essential peptide processing enzymes subtilisin-like prohormone convertases and Carboxy Peptidase B-like (CPB) enzymes were also identified in Chlamydomonas reinhardtii soluble mating secretome. After screening 771 soluble proteins in Chlamydomonas reinhardtii secretome which predicted to contain an N-terminal signal peptide were found to have subtilisin-like Prohormone Convertase (PC) cleavage sites ((R/K)Xn(R/K)↓, where n = 0 or 2, and ↓ identifies the cleavage site) in 756 proteins and furin-like cleavage sites (RX(K/R)R) in 224 proteins out of which 33 could yield amidated peptides which further strengthen our hypothesis of chimeric virus [33].
Exaggerated vasculotropic effect
The exaggerated vasculotropic effect likely due to its chimeric nature. Firstly the role of this transgenic microalgae as a manufacturing hub for recombinant bioactive proteins like VEGF, HMBG1 and Fibronectin has been already proved in last two decades. Secondly the presence of various protein kinase cascades in proteome of Chlamydomonas reinhardtii likely to be responsible for the same as the role of c AMP-dependent Protein Kinase A (PKA) regulates angiogenesis during embryogenesis also supports the same which was studied and published recently [34].Confirms “selection through passage” in cell lines
This chimera’s imitating features with SARS-CoV-2 like polybasic furin cleavage, O-linked glycans, high population density of reservoir (plant like animal) host, ACE2 enhancing genes similar to human ortholog, various unique RNA enzymes not only strongly support this hypothesis but also answers the queries of origin of virus in laboratory ie “Selection through passage” in Chlamydomonas reinhardtii cell lines and transfer from zoonotic reservoir to humans followed by human to human transmission [35].
Shocking atypical manifestations
Most of the cases remain asymptomatic or mildly symptomatic only few developed moderate to severe illness. Apart from typical SARS-CoV like features ie-; fever, chills, malaise, bodyache, dry cough, bilateral pneumonia, hepatic, renal, cardiac and deranged coagulation profile [36] the various others atypical presentations which have been frequently popped out and shocked scientists and research lobbies globally [37]. These could be best explained by this chimera. (Table 1).
Possible future effective vaccines
In this difficult situation of pandemic and economic crisis the possible operative strategies for COVID-19 vaccines development are limited. The live attenuated oral/nasal spray or recombinant subunit vaccines by using genetically modified Chlamydomonas reinhardtii as a biocapsule or nanoparticles would remain very effective if above hypothesis stands correct after research [54]. The antigen which should be used in such vaccines are protein or a portion of the spike protein domain and receptor binding domain [55]. In last few months the role of BCG, MMR and OPV like live attenuated vaccines have shown some nonspecific T cell mediated immune response which could be due to phylogenetic relationship of this Last Eukaryotic Common Ancestor (LECA) [56,57]. Replacing the wild strain of SARS-CoV-2 with vaccine virus to create a herd immunity could be a robust strategy [58]. The use of Anti proteome/SOUL3/Heam binding protein antibodies could be therapeutically useful. One should also consider air decontamination through Chlamydomonas reinhardtii based nanoparticles fogging for mass coverage of containment zones which was effectively executed for air pollution control measures in some countries. The recently developed recombinant vaccines using Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious virus should be our future vision [59].
Conclusion
Finally to conclude SARS-CoV-2 is a chimeric virus most likely evolved in laboratory over the years accidentally due to passing through the Chlamydomonas reinhardtii cell lines while making new generation vaccines. The above hypothesis strongly appears to be correct which have excellent research implications in future vaccines production. Incorporation of microalgae genes and proteins has conferred this novel Coronavirus-2019 with unique and hitherto unexplained features that cause atypical clinical presentations of this viral infection. The future vaccine development should also be targeted towards its chimeric spike protein (Chlamydomonas reinhardtii SOUL protein) to prevent its further spread and infectivity in humans.
- Yu Chen, Qianyun Liu, Deyin Guo. Emerging corornaviruses: Genome structure, replication and pathogenesis. J Med Virol. 2020; 92: 418-423. DOI: 10.1002/jmv.25681
- Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020; 395: 565-574. DOI: 10.1016/S0140-6736(20)30251-8
- Sasso S, Stibor H, Mittag M, Grossman AR. From molecular manipulation of domesticated Chlamydomonas reinhardtii to survival in nature. Elife. 2018; 7: 39233. DOI: 10.7554/eLife.39233
- Beth A Rasala, Machiko Muto, Philip A Lee, Michal Jager, Rosa MF Cardoso, Craig A Behnke, et al. Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol J. 2010; 8: 1-15. DOI: 10.1111/j.1467-7652.2010.00503.x
- Sabeeha S Merchant, Simon E Prochnik, Olivier Vallon, Elizabeth H Harris, Steven J Karpowicz, George B Witman, et al. The chlamydomonas genome reveals the evolution of key animal and plant functions. Science. 2007; 5848: 245-250. DOI: 10.1126/science.1143609
- Robert H Yolken, Lorraine Jones Brando, David D Dunigan, Geetha Kannan, Faith Dickerson, Emily Severance, et al. Chlorovirus ATCV-1 is part of the human oropharyngeal virome and is associated with changes in cognitive functions in humans and mice. Proc Natl Acad Sci. 2014; 111: 16106-16111. DOI: 10.1073/pnas.1418895111
- Bernardo Bañuelos-Hernández, Elizabeth Monreal Escalante, Omar González Ortega, Carlos Angulo, Sergio Rosales Mendoza. Algevir: An expression system for microalgae based on viral vectors. Front Microbiol. 2017; 8: 1100. DOI: 10.3389/fmicb.2017.01100
- Xing-Yi Ge, Jia-Lu Li, Xing Lou Yang, Aleksei A Chmura, Guangjian Zhu, Jonathan H Epstein, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Nature. 2013; 503: 535–538. DOI: 10.1038/nature12711
- Poh Lian Lim, Asok Kurup, Gowri Gopalakrishna, Kwai Peng Chan, Christopher W Wong, Lee Ching Ng, et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med. 2004; 350: 1740–1745. DOI: 10.1056/NEJMoa032565
- Anthony E Gregory, Richard Titball, Diane Williamson. Vaccine delivery using nanoparticles. Front Cell Infect Microbiol. 2013; 3: 13. DOI: 10.3389/fcimb.2013.00013
- Sandra Gohrbandt, Jutta Veits, Angele Breithaupt, Jana Hundt, Jens P Teifke, Olga Stech, et al. H9 avian influenza reassortant with engineered polybasic cleavage site displays a highly pathogenic phenotype in chicken. Virol. 2011; 92: 1843-1853. DOI: 10.1099/vir.0.031591-0
- Tam JS. Influenza a (H5N1) in Hong Kong: An overview. Vaccine. 2002; 20: 77-81. DOI: 10.1016/s0264-410x(02)00137-8
- Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020; 395: 565-574. DOI: 10.1016/S0140-6736(20)30251-8
- Anthonisen IL, Salvador ML, Klein U. Specific sequence elements in the 5¢ untranslated regions of rbcL and atpB genemRNAs stabilize transcripts in the chloroplast of Chlamydomonas reinhardtii. RNA. 2001; 7: 1024-1033. DOI: 10.1017/s1355838201001479
- Yang P, Yang C, Sale WS. Flagellar radial spoke protein 2 is a calmodulin binding protein required for motility in Chlamydomonas reinhardtii. Eukaryot Cell. 2004; 3: 72-81. DOI: 10.1128/EC.3.1.72-81.2004
- Yang C, Compton MM, Yang P. Dimeric novel HSP40 is incorporated into the radial spoke complex during the assembly process in flagella. Mol Biol Cell. 2005; 16: 637-648. DOI: 10.1091/mbc.e04-09-0787
- André Nordhues, Stephen M Miller, Timo Mühlhaus, Michael Schroda. New insights into the roles of molecular chaperones in chlamydomonas and volvox. Int Rev Cell Mol Biol. 2010; 285: 75-113. DOI: 10.1016/B978-0-12-381047-2.00002-5
- Matsuda Y, Kubo T. Gametolysin. In Handbook of Proteolytic Enzymes, Academic Press: New York; 2004; 2nd ed. 1140-1143.
- Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020; 582: 289-293. DOI: 10.1038/s41586-020-2223-y
- Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181: 271-280. DOI: 10.1016/j.cell.2020.02.052
- Celma Estefanía Ochoa Méndez, Ignacio Lara Hernández, Luzmila Martínez González, Patricia AguirreBañuelos, Maximiliano Ibarra Barajas, Patricia Castro Moreno, et al. Bioactivity of an antihypertensive peptide expressed in Chlamydomonas reinhardtii. J Biotechnol. 2016; 240: 76-84. DOI: 10.1016/j.jbiotec.2016.11.00
- Ruth E Soria-Guerra, Jocelín I Ramírez Alonso, Alejandro Ibáñez Salazar, Dania O Govea-Alonso, Luz MT Paz-Maldonado,Bernardo Bañuelos Hernández, , et al. Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine. Plant Cell Tiss Organ Cult. 2014 116: 133-139. https://bit.ly/2FusxfI
- Ziebuhr J. The coronavirus replicase. Curr Top Microbiol Immunol. 2005; 287: 57-94. DOI: 10.1007/3-540-26765-4_3
- Zimmer SL, Fei Z, Stern DB. Genome-based analysis of Chlamydomonas reinhardtii Exoribonucleases and Poly(A) Polymerases Predicts Unexpected Organellar and Exosomal Features. Genetics. 2008; 179: 125-136. DOI: 10.1534/genetics.107.086223
- Zylka MJ, Reppert SM. Discovery of a putative heme-binding protein family (SOUL/HBP) by two-tissue suppression subtractive hybridization and database searches. Brain Res Mol Brain Res. 1999; 74: 175-181. DOI: 10.1016/S0169-328X(99)00277-6
- Schulze T, Schreiber S, Iliev D, Boesger J, Trippens J, Kreimer G, et al. The heme-binding protein SOUL3 of Chlamydomonas reinhardtii influences size and position of the eyespot. Mol Plant 2012; 6: 931-944. DOI: 10.1093/mp/sss137
- Volker Wagner, Katharina Ullmann, Anne Mollwo, Marc Kaminski, Maria Mittag, Georg Kreimer. The phosphoproteome of a Chlamydomonas reinhardtii eyespot fraction includes key proteins of the light signaling pathway. Plant Physiol. 2008; 146: 772-788. DOI: 10.1104/pp.107.109645
- Lehtimäki N, Koskela MM, Mulo P. Posttranslational modifications of chloroplast proteins: An emerging field. Plant Physiol. 2015; 168: 768-775. DOI: 10.1104/pp.15.00117
- Rice JC, Allis CD. Histone methylation versus histone acetylation: New insights into epigenetic regulation. Curr Opin Cell Biol. 2001; 13: 263-273. DOI: 10.1016/s0955-0674(00)00208-8
- Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020; 581: 215-220. DOI: 10.1038/s41586-020-2180-5
- Bollig K, Lamshöft M, Schweimer K, Marner FJ, Budzikiewicz H, Waffenschmidt S. Structural analysis of linear hydroxyproline-bound O-glycans of Chlamydomonas reinhardtii-conservation of the inner core in Chlamydomonas and land plants. Carbohydr Res. 2007; 342: 2557-2566. DOI: 10.1016/j.carres.2007.08.008
- Bagdonaite I, Wandall HH. Global aspects of viral glycosylation. Glycobiology. 2018; 28: 443-467. DOI: 10.1093/glycob/cwy021
- Dahms SO, Hardes K, Steinmetzer T, Than ME. X-Ray structures of the proprotein convertase furin bound with substrate analogue inhibitors reveal substrate specificity determinants beyond the s4 pocket. Biochemistry. 2018; 57: 925-934. DOI: 10.1021/acs.biochem.7b01124
- Pavel I Nedvetsky, Xiaocheng Zhao, Thomas Mathivet, Irene M Aspalter, Fabio Stanchi, Ross J Metzger, et al. cAMP-dependent protein kinase A (PKA) regulates angiogenesis by modulating tip cell behavior in a Notch-independent manner. Development. 2016; 143: 3582-3590. DOI: 10.1242/dev.134767
- Kristian G Andersen, Andrew Rambaut, W Ian Lipkin, Edward C Holmes, Robert F Garry. The proximal origin of SARS-CoV-2. Nat Med. 2020; 26: 450-452. DOI: 10.1038/s41591-020-0820-9
- Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395: 507-513. DOI: 10.1016/S0140-6736(20)30211-7
- Jarvis C. The unusual symptoms of COVID-19. The Scientist. 2020. https://bit.ly/32rWLZE
- Dombeck TA, Satonik RC. The porphyrias. Emerg Med Clin North Am 2005; 23: 885-899. DOI: 10.1016/j.emc.2005.03.014
- Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, et al. Aveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19. Research Square. 2020. DOI: 10.21203/rs.3.rs-19346/v1
- U Andersson, H Wang, K Palmblad, AC Aveberger, O Bloom, H Erlandsson-Harris, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000; 192: 565-570. DOI: 10.1084/jem.192.4.565
- Andersson U, Yang H, Harris H. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells. Semin Immunol. 2018; 38: 40-48. DOI: 10.1016/j.smim.2018.02.011
- Yonghyun Lee, Pokkee Min, Seonggu Lee, Shin Woo Kim. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020; 35: 174. DOI: 10.3346/jkms.2020.35.e174
- Patel RM, Pinto JM. Olfaction: anatomy, physiology, and disease. Clin Anat. 2014; 27: 54-60. DOI: 10.1002/ca.22338
- Li Y, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92: 552-555. DOI: 10.1002/jmv.25728
- Arjun V Pendharkar, Sabrina L Levy, Allen L Ho, Eric S Sussman, Michelle Y Cheng, Gary K Steinberg. Optogenetic modulation in stroke recovery. Neurosurg Focus. 2016; 40: E6. DOI: 10.3171/2016.2.FOCUS163
- Yingxia Liu, Yang Yang, Cong Zhang, Fengming Huang, Fuxiang Wang, Jing Yuan, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020; 63: 364-374. DOI: 10.1007/s11427-020-1643-8
- Vallon O. Chlamydomonas immunophilins and parvulins: Survey and critical assessment of gene models. Eukaryot Cell. 2005; 4: 836. DOI: 10.1128/EC.4.4.836.2005
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-57. Geneva, Switzerland, 2020. https://bit.ly/2FuC9qG
- Xiaolu Tang, Changcheng Wu, Xiang Li, Yuhe Song, Xinmin Yao, Xinkai Wu, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020; 7: 1012-1023. DOI: 10.1093/nsr/nwaa036
- Goodenough U, Lin H, Lee JH. Sex determination in Chlamydomonas. Semin Cell Dev Biol. 2007; 18: 350-361. DOI: 10.1016/j.semcdb.2007.02.006
- Genitsaris S, Kormas KA, Moustaka Gouni M. Airborne algae and cyanobacteria: Occurrence and related health effects. Front Biosci. 2011; 3: 772-787. DOI: 10.2741/e285
- Sharma NK, Rai AK, Singh S, Brown RM. Airborne algae: Their present status and relevance. J Phycol. 2007; 43: 615–627. DOI: 10.1111/j.1529-8817.2007.00373.x
- Qun Li, Xuhua Guan, Peng Wu, Xiaoye Wang, Lei Zhou, Yeqing Tong, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020; 382: 1199-1207. DOI: 10.1056/NEJMoa2001316
- Daniel Norero. Italy and Israel bet on GM microalgae to develop edible COVID vaccine. 2020. https://bit.ly/2GRifXu
- Specht EA, Mayfield SP. Algae-based oral recombinant vaccines. Front Microbiol. 2014; 5: 60. DOI: 10.3389/fmicb.2014.00060
- Robin Franklin, Adam Young, Bjoern Neumann, Rocio Fernandez, Alexis Joannides, Amir Reyahi, et al. Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19. medRxi. DOI: 10.1101/2020.04.10.20053207
- Konstantin Chumakov, Christine S Benn, Peter Aaby, Shyamasundaran Kottilil, Robert Gallo. Can existing live vaccines prevent COVID-19?. Science. 2020; 368: 1187-1188. DOI: 10.1126/science.abc4262
- D`Souza GA, Dowdy D. What is herd immunity and how can we achieve it with COVID-19? https://bit.ly/2FgXeFr
- Nakahashi-Ouchida R, Yuki Y, Kiyono H. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases. Hum Vaccin Immunother. 2018; 14: 2189-2193. DOI: 10.1080/21645515.2018.1461298
Sign up for Article Alerts